Adefovir for lamivudine-resistant hepatitis B
Adefovir, a nucleotide analog developed by John Martin, was a major breakthrough in the treatment of chronic Hepatitis B. Prior to adefovir, Hepatitis B treatment was limited to two therapeutic modalities, either interferon, which carried significant side effects and was efficacious in a minority of...
| Published in: | Antiviral Therapy |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-04-01
|
| Online Access: | https://doi.org/10.1177/13596535211067605 |